Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28
LAVAL, Quebec, Feb. 6, 2018 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
Conference Call Details | |
Date: | Wednesday, Feb. 28, 2018 |
Time: | 8:00 a.m. EST |
Webcast: | |
Participant Event Dial-in: | (844) 428-3520 (North America) |
(409) 767-8386 (International) | |
Participant Passcode: | 5287247 |
Replay Dial-in: | (855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode: | 5287247 (replay available until Apr. 28, 2018) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(514) 856-3855 | (908) 927-0617 |
(877) 281-6642 (toll free) |
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-fourth-quarter-and-full-year-2017-financial-results-on-february-28-300594219.html
SOURCE Valeant Pharmaceuticals International, Inc.
